|
|
|
20:12.14 Platelet-Reducing Agents |
|
91:04.32 Fluoropyrimidine Antidote |
|
91:32.04 Gaba-Mediated Benzodiazepine Antidotes |
|
92:00 Miscellaneous Therapeutic Agents |
|
|
|
|
|
|
|
|
|
|
|
92:26 Carbonic Anhydrase Inhibitors |
|
|
|
|
|
|
|
|
|
|
|
92:56 Protective Agents |
|
|
|
20:24 Hemorrheologic Agents |
|
20:28.08 Antiheparin Agents |
- Aminocaproic Acid
- Antihemophilic Factor (Human)
- Antihemophilic Factor (Recombinant)
- Antihemophilic Factor (Recombinant), Fc Fusion Protein
- Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl
- Antihemophilic Factor (Recombinant), Glycopegylated-Exei
- Antihemophilic Factor (Recombinant), Pegylated
- Antihemophilic Factor (Recombinant), Pegylated-Aucl
- Antihemophilic Factor (Recombinant), Porcine Sequence
- Antihemophilic Factor (Recombinant), Single Chain
- Anti-Inhibitor Coagulant Complex
- Coagulation Factor IX (Recombinant), Glycopegylated
- Coagulation Factor Xa (Recombinant), Inactivated-Zhzo
- Concizumab-Mtci
- Emicizumab-Kxwh
- Factor IX (Human), Factor IX Complex (Human)
- Factor IX (Recombinant)
- Factor IX (Recombinant), Albumin Fusion Protein
- Factor IX (Recombinant), Fc Fusion Protein
- Factor Viia (Recombinant)
- Factor X (Human)
- Factor XIII (Human)
- Factor XIII A-Subunit (Recombinant)
- Fibrinogen (Human)
- Fitusiran
- Marstacimab-Hncq
- Prothrombin Complex Concentrate (Human)
- Thrombin (Bovine)
- Thrombin (Human)
- Thrombin Alfa (Recombinant)
- Tranexamic Acid
- Von Willebrand Factor (Recombinant)
|
|
20:28.92 Antihemorrhagic Agents, Miscellaneous |
|
|
|
24:00 Cardiovascular Drugs |
|
|
|
|
|
|
|
|
|
|
|
|
